Advertisement

Index by author

January 01, 2024; Volume 388,Issue 1

  1. Wade, Anna

    1. Pantothenate Kinase Activation Restores Brain Coenzyme A in a Mouse Model of Pantothenate Kinase-Associated Neurodegeneration
      Open Access
      Pantothenate Kinase Activation Restores Brain Coenzyme A in a Mouse Model of Pantothenate Kinase-Associated Neurodegeneration
      Chitra Subramanian, Matthew W. Frank, Rajaa Sukhun, Christopher E. Henry, Anna Wade, Mallory E. Harden, Satish Rao, Rajendra Tangallapally, Mi-Kyung Yun, Stephen W. White, Richard E. Lee, Uma Sinha, Charles O. Rock and Suzanne Jackowski
      Journal of Pharmacology and Experimental Therapeutics January 2024, 388 (1) 171-180; DOI: https://doi.org/10.1124/jpet.123.001919

  2. Wagg, Cory S.

    1. Obesity Is a Major Determinant of Impaired Cardiac Energy Metabolism in Heart Failure with Preserved Ejection Fraction
      Obesity Is a Major Determinant of Impaired Cardiac Energy Metabolism in Heart Failure with Preserved Ejection Fraction
      Berna Güven, Qiuyu Sun, Cory S. Wagg, Amanda Almeida de Oliveira, Heidi Silver, Kaya L. Persad, Arzu Onay-Besikci, Jennie Vu, Gavin Y. Oudit and Gary D. Lopaschuk
      Journal of Pharmacology and Experimental Therapeutics January 2024, 388 (1) 145-155; DOI: https://doi.org/10.1124/jpet.123.001791

  3. Wang, Guanglin

    1. Preclinical Pharmacology Characterization of Sovleplenib (HMPL-523), an Orally Available Syk Inhibitor
      Preclinical Pharmacology Characterization of Sovleplenib (HMPL-523), an Orally Available Syk Inhibitor
      Yu Cai, Jianlin He, Zhipeng Wu, Weigang He, Xiaoming Dai, Yan Xu, Min Cheng, Na Yang, Yongxin Ren, Guanglin Wang, Jian Wang, Yang Sai, Hong Jia, Guangxiu Dai, Xiong Li and Weiguo Su
      Journal of Pharmacology and Experimental Therapeutics January 2024, 388 (1) 156-170; DOI: https://doi.org/10.1124/jpet.123.001752

  4. Wang, Jian

    1. Preclinical Pharmacology Characterization of Sovleplenib (HMPL-523), an Orally Available Syk Inhibitor
      Preclinical Pharmacology Characterization of Sovleplenib (HMPL-523), an Orally Available Syk Inhibitor
      Yu Cai, Jianlin He, Zhipeng Wu, Weigang He, Xiaoming Dai, Yan Xu, Min Cheng, Na Yang, Yongxin Ren, Guanglin Wang, Jian Wang, Yang Sai, Hong Jia, Guangxiu Dai, Xiong Li and Weiguo Su
      Journal of Pharmacology and Experimental Therapeutics January 2024, 388 (1) 156-170; DOI: https://doi.org/10.1124/jpet.123.001752

  5. Wang, Shiyu

    1. Gene Polymorphisms and Drug–Drug Interactions Determine the Metabolic Profile of Blonanserin
      Feng Ye, Xinyue Li, Jinhuan Ni, Xiaoyu Xu, Jianchao Luo, Yunshan Zhong, Yahui Wang, Shiyu Wang, Yuqing Zhang, Guoxin Hu and Jianchang Qian
      Journal of Pharmacology and Experimental Therapeutics January 2024, 388 (1) 190-200; DOI: https://doi.org/10.1124/jpet.123.001767

  6. Wang, Yahui

    1. Gene Polymorphisms and Drug–Drug Interactions Determine the Metabolic Profile of Blonanserin
      Feng Ye, Xinyue Li, Jinhuan Ni, Xiaoyu Xu, Jianchao Luo, Yunshan Zhong, Yahui Wang, Shiyu Wang, Yuqing Zhang, Guoxin Hu and Jianchang Qian
      Journal of Pharmacology and Experimental Therapeutics January 2024, 388 (1) 190-200; DOI: https://doi.org/10.1124/jpet.123.001767

  7. White, Stephen W.

    1. Pantothenate Kinase Activation Restores Brain Coenzyme A in a Mouse Model of Pantothenate Kinase-Associated Neurodegeneration
      Open Access
      Pantothenate Kinase Activation Restores Brain Coenzyme A in a Mouse Model of Pantothenate Kinase-Associated Neurodegeneration
      Chitra Subramanian, Matthew W. Frank, Rajaa Sukhun, Christopher E. Henry, Anna Wade, Mallory E. Harden, Satish Rao, Rajendra Tangallapally, Mi-Kyung Yun, Stephen W. White, Richard E. Lee, Uma Sinha, Charles O. Rock and Suzanne Jackowski
      Journal of Pharmacology and Experimental Therapeutics January 2024, 388 (1) 171-180; DOI: https://doi.org/10.1124/jpet.123.001919

  8. Wiktorowska-owczarek, Anna

    1. Open Access
      Ketamine – A New Antidepressant Drug with Anti-Inflammatory Properties
      Marta Jóźwiak-Bębenista, Paulina Sokołowska, Anna Wiktorowska-Owczarek, Edward Kowalczyk and Monika Sienkiewicz
      Journal of Pharmacology and Experimental Therapeutics January 2024, 388 (1) 134-144; DOI: https://doi.org/10.1124/jpet.123.001823

  9. Wood, Susan

    1. Moving the Journal of Pharmacology and Experimental Therapeutics Forward to Address the Needs of Our Authors and Editors—Editorial
      Beverley Greenwood Van Meerveld, Roberto Levi, Eric R. Gross, Joe Blumer and Susan Wood
      Journal of Pharmacology and Experimental Therapeutics January 2024, 388 (1) 1-5; DOI: https://doi.org/10.1124/jpet.123.001988

  10. Wu, Zhipeng

    1. Preclinical Pharmacology Characterization of Sovleplenib (HMPL-523), an Orally Available Syk Inhibitor
      Preclinical Pharmacology Characterization of Sovleplenib (HMPL-523), an Orally Available Syk Inhibitor
      Yu Cai, Jianlin He, Zhipeng Wu, Weigang He, Xiaoming Dai, Yan Xu, Min Cheng, Na Yang, Yongxin Ren, Guanglin Wang, Jian Wang, Yang Sai, Hong Jia, Guangxiu Dai, Xiong Li and Weiguo Su
      Journal of Pharmacology and Experimental Therapeutics January 2024, 388 (1) 156-170; DOI: https://doi.org/10.1124/jpet.123.001752
Back to top

In this issue

Advertisement